The E-Eye generates a polychromatic-pulsed light set to stimulate the meibomian glands, enabling them to return to their normal function. Medically certified in Europe and TGA registered in Australia, the E-Eye
was launched in Australia and New Zealand last year (2013).
After a first relevant clinical study run in France in 2011, A/Prof Jennifer Craig has recently revealed the results of her double masked clinical study realised in New Zealand early 2014. The study has highlighted the great potential of IPL to cure Meibomian Gland Dysfunction (MGD). With 86 per cent of patients noting significant improvement after the test, France Medical claims “the E-Eye is probably one of the most effective solutions in the treatment of dry eye nowadays”.
Contact: France Medical (AUS) 07 3151 1543